CMS has confirmed that ambulatory surgery centers will continue to receive separate Medicare reimbursement in 2026 for certain non-opioid pain management devices under the NOPAIN Act, including three approved products used in ASC and outpatient hospital settings. The decision reinforces ongoing efforts to support non-opioid pain management options following surgical procedures when medically necessary.
Resource: CMS finalizes separate payment for 3 non-opioid ASC pain devices